Promising to “get the data, house the data, mine the data, apply the data and offer solutions,” a team of healthcare veterans announced the launch Wednesday of Humedica.

The Boston-based provider of healthcare informatics solutions, in planning for 15 months, was launched with $30 million in capital from Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners and Leerink Swann and a long-term relationship forged with the American Medical Group Association. The company now offers a Software-as-a-Service-based business analytics portfolio centering on the Humedica MindShare platform and Humedica MindStream predictive clinical surveillance system.

“Evidence-based healthcare is the name of the game,” said Michael Weintraub, the company’s president and CEO, a 25-year veteran of the healthcare informatics industry and former president and CEO of PHARMetrics.

Weintraub said much of the data-gathering taking place in healthcare now is claims-based, and that Humedica is focused on developing longitudinal, census-driven databases more appropriate for clinical decision-making, including studies and chronic disease management programs.

“Through our innovative solutions, Humedica offers a complete picture of healthcare delivery, bringing together clinical, operational and financial data to help answer both pressing real-time questions and to address topics at the center of healthcare reform that require comparative analyses and benchmarking information,” he added.

“The data’s a mess and it’s lying all over the place – which we already knew,” said A.G. Breitenstein, who founded both PrivaSource and the Institute for Health Metrics and is Humedica’s vice president and general manager of provider markets. “Providers have all sorts of different systems in place, and they haven’t focused on making that data available for use.”

Humedica has been testing products at CHRISTUS Health, a Texas-based healthcare system of 40 hospitals and other healthcare providers in Texas, Louisiana, Arkansas, Utah, Oklahoma, Missouri and Georgia, as well as Mexico. Breitenstein said the company rolled out its retrospective analytics tools about two weeks ago and will be rolling out real-time analytics software within the month.

“Placing data in the hands of our physicians is key to driving continuously superior performance and improved care for our patients,” said Michael Finley, MD, vice president of medical affairs for Christus Health at St. Michael’s Hospital in Texarkana, Texas. “Humedica MindShare is an incredibly user-friendly tool that delivers an informative set of pre-built reports with excellent views and graphs. Our ability to configure the data and explore aspects of patient care, such as complications, in greater detail is exciting and key to our performance improvement strategy.”

Allen Kamer, who founded MORPACE Pharma and was director of decision support at Biogen Idec and now serves as vice president of corporate development and planning, said Humedica is able to deliver specific data that wasn’t available to healthcare providers five years ago. He said the data can be used in real-time by providers for clinical decision support and de-identified and encrypted for life sciences functions.

“We’re able to follow the patient from the doctor’s office to the hospital and back to the doctor’s office,” he said.

“Complexity is actually going to be a strategic advantage,” added Weintraub.

Humedica’s management team also consist of Paul Bleicher, MD, the company’s chief medical officer; Steve Davis, vice president and general manager of life sciences; Stan Huang, vice president of engineering; Stan Norton, vice president of operations; Donald Pettini, chief technology officer; and Bill Romeo, chief financial officer.